Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Machens

Showing results (131-140 of 157) with videos related to

Pageof 16
Sort By:
Surgery|April 28, 2016
Impact of central node dissection on postoperative morbidity in pediatric patients with suspected or proven thyroid cancerAndreas Machens, Malik Elwerr, Phuong Nguyen Thanh, et al.
Gland Surgery|November 17, 2017
Opportunities and challenges of intermittent and continuous intraoperative neural monitoring in thyroid surgeryRick Schneider, Andreas Machens, Gregory W Randolph, et al.
The Journal of Clinical Endocrinology and Metabolism|March 17, 2023
The Changing Face of Multiple Endocrine Neoplasia 2A: From Symptom-Based to Preventative MedicineAndreas Machens, Kerstin Lorenz, Tim Brandenburg, et al.
Endocrine-Related Cancer|May 16, 2024
Genotype-specific development of MEN 2 constituent components in 683 RET carriersAndreas Machens, Kerstin Lorenz, Frank Weber, et al.
Endocrine|July 21, 2023
Clinical presentation of MEN 2A in index vs. non-index patientsAndreas Machens, Kerstin Lorenz, Frank Weber, et al.
Clinical Endocrinology|November 25, 2011
Clinical relevance of RET variants G691S, L769L, S836S and S904S to sporadic medullary thyroid cancerAndreas Machens, Karin Frank-Raue, Kerstin Lorenz, et al.
Annals of Surgery|August 28, 2013
Surgical curability of medullary thyroid cancer in multiple endocrine neoplasia 2B: a changing perspectiveMichael Brauckhoff, Andreas Machens, Kerstin Lorenz, et al.
The Journal of Clinical Endocrinology and Metabolism|April 14, 2005
Codon-specific development of pheochromocytoma in multiple endocrine neoplasia type 2Andreas Machens, Michael Brauckhoff, Hans-Jürgen Holzhausen, et al.
European Journal of Endocrinology|December 6, 2012
Molecular epidemiology of multiple endocrine neoplasia 2: implications for RET screening in the new milleniumAndreas Machens, Kerstin Lorenz, Carsten Sekulla, et al.
Surgery|December 2, 2008
Premonitory symptoms preceding metastatic medullary thyroid cancer in MEN 2B: An exploratory analysisMichael Brauckhoff, Andreas Machens, Sören Hess, et al.
Pageof 16

Showing results (131-140 of 157) with videos related to

Sort By:
Pageof 16
Surgery|April 28, 2016
Impact of central node dissection on postoperative morbidity in pediatric patients with suspected or proven thyroid cancerAndreas Machens, Malik Elwerr, Phuong Nguyen Thanh, et al.
Gland Surgery|November 17, 2017
Opportunities and challenges of intermittent and continuous intraoperative neural monitoring in thyroid surgeryRick Schneider, Andreas Machens, Gregory W Randolph, et al.
The Journal of Clinical Endocrinology and Metabolism|March 17, 2023
The Changing Face of Multiple Endocrine Neoplasia 2A: From Symptom-Based to Preventative MedicineAndreas Machens, Kerstin Lorenz, Tim Brandenburg, et al.
Endocrine-Related Cancer|May 16, 2024
Genotype-specific development of MEN 2 constituent components in 683 RET carriersAndreas Machens, Kerstin Lorenz, Frank Weber, et al.
Endocrine|July 21, 2023
Clinical presentation of MEN 2A in index vs. non-index patientsAndreas Machens, Kerstin Lorenz, Frank Weber, et al.
Clinical Endocrinology|November 25, 2011
Clinical relevance of RET variants G691S, L769L, S836S and S904S to sporadic medullary thyroid cancerAndreas Machens, Karin Frank-Raue, Kerstin Lorenz, et al.
Annals of Surgery|August 28, 2013
Surgical curability of medullary thyroid cancer in multiple endocrine neoplasia 2B: a changing perspectiveMichael Brauckhoff, Andreas Machens, Kerstin Lorenz, et al.
The Journal of Clinical Endocrinology and Metabolism|April 14, 2005
Codon-specific development of pheochromocytoma in multiple endocrine neoplasia type 2Andreas Machens, Michael Brauckhoff, Hans-Jürgen Holzhausen, et al.
European Journal of Endocrinology|December 6, 2012
Molecular epidemiology of multiple endocrine neoplasia 2: implications for RET screening in the new milleniumAndreas Machens, Kerstin Lorenz, Carsten Sekulla, et al.
Surgery|December 2, 2008
Premonitory symptoms preceding metastatic medullary thyroid cancer in MEN 2B: An exploratory analysisMichael Brauckhoff, Andreas Machens, Sören Hess, et al.
Pageof 16